Novo Nordisk A/S (NOVO-B.CO)

DKK 771.6

(0.22%)

Inventory Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual inventory in 2023 was 31.81 Billion DKK , up 30.44% from previous year.
  • Novo Nordisk A/S's latest quarterly inventory in 2024 Q2 was 36.35 Billion DKK , up 8.2% from previous quarter.
  • Novo Nordisk A/S reported annual inventory of 24.38 Billion DKK in 2022, up 24.3% from previous year.
  • Novo Nordisk A/S reported annual inventory of 19.62 Billion DKK in 2021, up 5.85% from previous year.
  • Novo Nordisk A/S reported quarterly inventory of 36.35 Billion DKK for 2024 Q2, up 8.2% from previous quarter.
  • Novo Nordisk A/S reported quarterly inventory of 31.81 Billion DKK for 2023 Q4, up 7.71% from previous quarter.

Annual Inventory Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Inventory of Novo Nordisk A/S (2023 - 1989)

Year Inventory Inventory Growth
2023 31.81 Billion DKK 30.44%
2022 24.38 Billion DKK 24.3%
2021 19.62 Billion DKK 5.85%
2020 18.53 Billion DKK 5.07%
2019 17.64 Billion DKK 7.99%
2018 16.33 Billion DKK 6.26%
2017 15.37 Billion DKK 7.2%
2016 14.34 Billion DKK 12.41%
2015 12.75 Billion DKK 12.34%
2014 11.35 Billion DKK 18.9%
2013 9.55 Billion DKK 0.09%
2012 9.54 Billion DKK 1.17%
2011 9.43 Billion DKK -2.64%
2010 9.68 Billion DKK -3.26%
2009 10.01 Billion DKK 3.97%
2008 9.63 Billion DKK 6.67%
2007 9.03 Billion DKK 7.56%
2006 8.39 Billion DKK 8.03%
2005 7.77 Billion DKK 7.79%
2004 7.21 Billion DKK 10.07%
2003 6.55 Billion DKK 10.85%
2002 5.9 Billion DKK 24.55%
2001 4.74 Billion DKK 19.51%
2000 3.97 Billion DKK -18.75%
1999 4.88 Billion DKK 5.28%
1998 4.64 Billion DKK 70.93%
1997 2.71 Billion DKK 8.18%
1996 2.51 Billion DKK 10.47%
1995 2.27 Billion DKK -8.35%
1994 2.47 Billion DKK 20.49%
1993 2.05 Billion DKK 23.41%
1992 1.66 Billion DKK 19.36%
1991 1.39 Billion DKK 17.79%
1990 1.18 Billion DKK -10.67%
1989 1.32 Billion DKK 17.97%

Peer Inventory Comparison of Novo Nordisk A/S

Name Inventory Inventory Difference
ALK-Abelló A/S 1.42 Billion DKK -2135.488%
Bavarian Nordic A/S 1.64 Billion DKK -1835.286%
Genmab A/S 57 Million DKK -55708.772%
Gubra A/S -403.98 Million DKK 7974.224%
Orphazyme A/S -1099.00 DKK 2894540591.356%
Pharma Equity Group A/S 1000.00 DKK -3181099900.0%
Zealand Pharma A/S 7.93 Million DKK -400794.77%